查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930059

連續性腎臟替代療法 (CRRT) 市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察，2025-2034 年

Continuous Renal Replacement Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

連續性腎臟替代療法 (CRRT) 市場成長驅動因子

預計 2025 年全球連續性腎臟替代療法市場規模將達到 12.5 億美元，2026 年將達到 13.4 億美元。預計到 2034 年，該市場規模將最終成長至 25.2 億美元，預測期內複合年增長率 (CAGR) 為 8.20%。北美地區在 2025 年將以 39.72% 的市佔率領先，這主要歸功於急性腎損傷 (AKI) 盛行率的上升、先進的醫療基礎設施以及 CRRT 在重症監護室 (ICU) 的廣泛應用。主要參與者包括百特（Baxter）、費森尤斯醫療股份公司（Fresenius Medical Care AG & Co. KGaA）和貝朗（B. Braun SE），他們致力於技術創新和產品拓展。

連續性腎臟替代療法（CRRT）是一種專門針對血流動力學不穩定和急性腎損傷重症患者的透析技術。與間歇性血液透析不同，CRRT 每天 24 小時持續運行，逐步清除代謝廢物、體液和電解質。這最大限度地減少了血流動力學的突然變化，並能更接近地模擬自然腎功能，因此對於重症監護室（ICU）中多重器官衰竭的患者尤其有效。

市場驅動因素

重症監護室（ICU）入院人數增加和急性腎損傷（AKI）盛行率上升：AKI 的發生率在全球範圍內不斷上升，尤其是在重症患者中。例如，英國腎臟登記處報告稱，2023 年急性腎損傷 (AKI) 病例數為 683,136 例，比 2022 年增長 15.8%。慢性疾病、敗血症和 COVID-19 併發症導致的重症監護室 (ICU) 入院人數增加，進一步推動了對連續性腎臟替代療法 (CRRT) 的需求，CRRT 可在維持血流動力學穩定的同時提供持續的腎臟支持。

技術進步：CRRT 系統正在不斷發展，自動化程度更高，液體管理更加精細，並整合了人工智慧 (AI) 以進行即時患者監測。 2021 年 5 月，百特公司推出了 PrisMax2，可提供更完善的器官支援和液體管理。這些技術創新正在推動市場成長。

兒科 CRRT 設備：兒科重症監護室患者急性腎損傷 (AKI) 發病率的增加創造了新的成長機會。兒科專用 CRRT 系統能夠根據特定的生理需求進行個人化治療，而不是簡單地從成人數據推斷。監管機構的批准，例如美國食品藥物管理局 (FDA) 於 2024 年 9 月將兒科 CRRT 設備列為 II 類醫療器械，正在促進其安全實施。

市場限制因子

高昂成本：CRRT 系統和耗材的高昂初始成本（估計每天 870 美元，而間歇性血液透析為 270 美元）限制了其在對成本敏感的醫療機構（尤其是在發展中地區）的普及。缺乏熟練的專業人員以及 CRRT 設置的複雜性進一步阻礙了其廣泛應用。

市場機會

將人工智慧與家庭 CRRT 解決方案結合：近期的一些撥款和研究計劃，例如美國於 2023 年 6 月提供的 380 萬美元人工智慧撥款，旨在優化 CRRT 的療效。便攜式家庭 CRRT 解決方案的出現，將市場潛力擴展到醫院重症監護室 (ICU) 之外。

市場區隔

依產品類型劃分：耗材細分市場將在2026年佔領先地位，市佔率達73.34%，主要得益於過濾器、透析液、導管和置換液的重複使用。系統細分市場預計將穩定成長，這得益於已開發國家對先進 CRRT 設備的廣泛應用。

按療法劃分：連續性靜脈-靜脈血液透析濾過 (CVVHDF) 透過擴散和對流有效清除溶質，預計將在 2026 年佔市場主導地位，市場佔有率達 45.55%。其他療法（CVVHD、CVVH、SCUF 等）預計將隨著其臨床應用範圍的擴大而逐步成長。

依地區劃分

  • 北美：受急性腎損傷 (AKI) 高發生率、重症監護室 (ICU) 基礎設施建設以及先進 CRRT 系統應用等因素的推動，北美市場預計將佔主導地位，2025 年市場規模將達到 4.2 億美元，2026 年將達到 4.5 億美元。預計到 2026 年，美國市場規模將達到 4.9 億美元。
  • 歐洲：受腎臟疾病發病率上升和政府對腎臟護理的重視推動，英國和德國預計將成為第二大市場，到2026年分別達到7000萬美元和1億美元。 亞太地區：成長最快的地區。受人口老化和重症監護室（ICU）急性腎損傷（AKI）高發生率的推動，預計到2026年，日本將達到6,000萬美元，中國將達到8,000萬美元，印度將達到3,000萬美元。 拉丁美洲、中東和非洲：預計成長適中。重症監護室患者中連續性腎臟替代療法（CRRT）的日益普及以及與全球公司的策略合作將推動成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家急性腎衰竭流行病學（2025 年）
  • 主要國家和地區的健保報銷情況
  • 主要公司新產品發布
  • 關鍵產業趨勢：併購與合作
  • 新冠疫情對市場的影響

第五章：全球連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測 (2021-2034)

  • 市場分析、洞察與預測 - 按產品類型劃分
    • 系統
    • 耗材
      • 透析液
      • 置換液
      • 過濾器（血液濾過器、血漿濾過器、其他）
      • 導管
      • 其他
  • 市場分析、洞察與預測 - 按療法劃分
    • 慢速連續超濾 (SCUF)
    • 連續性靜脈-靜脈血液濾過 (CVVH)
    • 連續性靜脈-靜脈血液透析 (CVVHD)
    • 連續性靜脈-靜脈血液透析濾過 (CVVHDF)
  • 市場分析、洞察、及預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測 (2021-2034)

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測 (2021-2034)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞半島
    • 其他地區歐洲

第八章 亞太地區連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測 (2021-2034)

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測 (2021-2034)

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東和非洲連續性腎臟替代療法 (CRRT) 市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 南非
    • 海灣合作委員會
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • 百特
    • 貝朗集團
    • 費森尤斯醫療股公司
    • 旭化成醫療株式會社（旭化成株式會社）
    • 尼普洛株式會社
    • 東麗醫療株式會社（東麗工業株式會社）
    • 日機裝株式會社
    • 美敦力
Product Code: FBI102547

Growth Factors of Continuous Renal Replacement Therapy (CRRT) Market

The global Continuous Renal Replacement Therapy (CRRT) market was valued at USD 1.25 billion in 2025 and is projected to reach USD 1.34 billion in 2026, ultimately expanding to USD 2.52 billion by 2034, exhibiting a CAGR of 8.20% during the forecast period. North America dominated the market in 2025 with a 39.72% share, driven by the rising prevalence of acute kidney injury (AKI), advanced healthcare infrastructure, and growing adoption of CRRT in intensive care units (ICUs). Key players include Baxter, Fresenius Medical Care AG & Co. KGaA, and B Braun SE, focusing on technological innovation and product expansion.

CRRT is a specialized form of dialysis designed for critically ill patients with hemodynamic instability and acute kidney injury. Unlike intermittent hemodialysis, CRRT operates continuously over 24 hours, allowing gradual removal of waste, fluids, and electrolytes. This minimizes rapid hemodynamic changes and closely mimics natural kidney function, making it particularly effective for patients with multiple organ failure in ICU settings.

Market Drivers

Increasing ICU Admissions and AKI Prevalence: Globally, the incidence of AKI is rising, particularly among critically ill patients. For instance, the UK Renal Registry reported 683,136 AKI cases in 2023, a 15.8% increase over 2022. Rising ICU admissions due to chronic conditions, sepsis, and COVID-19 complications have further boosted the demand for CRRT, as it provides continuous renal support while maintaining hemodynamic stability.

Technological Advancements: CRRT systems have evolved with enhanced automation, fluid management, and integration of artificial intelligence (AI) for real-time patient monitoring. In May 2021, Baxter launched PrisMax2, offering improved organ support and fluid management, demonstrating how innovation drives market growth.

Pediatric CRRT Devices: The increasing incidence of AKI among pediatric ICU patients presents a new growth opportunity. Specialized CRRT systems for children address unique physiological needs, allowing tailored treatment rather than relying on adult extrapolation. Regulatory approvals, such as the FDA classifying pediatric CRRT devices as Class II in September 2024, facilitate safer adoption.

Market Restraints

High Costs: The high upfront costs of CRRT systems and consumables, estimated at USD 870 per day compared to USD 270 for intermittent hemodialysis, limit adoption in cost-sensitive healthcare settings, particularly in developing regions. Shortage of skilled professionals and the complexity of CRRT setup further restrict widespread implementation.

Market Opportunities

Integration of AI and Home-Based CRRT Solutions: Recent grants and research initiatives, such as the USD 3.8 million U.S. AI grant in June 2023, aim to optimize CRRT outcomes. Portable and home-based CRRT solutions are emerging, expanding market potential beyond hospital ICUs.

Market Segmentation

By Product Type: In 2026, the consumables segment dominated with 73.34% share, driven by repetitive use of filters, dialysates, catheters, and replacement solutions. The systems segment is projected to grow steadily, supported by advanced CRRT devices in developed countries.

By Modality: Continuous Venovenous Hemodiafiltration (CVVHDF) led in 2026 with 45.55% share, due to its effective solute clearance through diffusion and convection. Other modalities, including CVVHD, CVVH, and SCUF, are expected to grow gradually with increasing clinical adoption.

By Region:

  • North America: Dominated with USD 0.42 billion in 2025 and USD 0.45 billion in 2026, driven by high AKI prevalence, ICU infrastructure, and adoption of advanced CRRT systems. The U.S. is projected to reach USD 0.49 billion by 2026.
  • Europe: Second-largest market with projected USD 0.07 billion (UK) and USD 0.1 billion (Germany) in 2026, supported by rising renal disorders and government focus on renal care.
  • Asia Pacific: Fastest-growing region; Japan USD 0.06 billion, China USD 0.08 billion, India USD 0.03 billion in 2026, due to aging populations and high ICU AKI incidence.
  • Latin America & Middle East & Africa: Moderate growth fueled by increasing adoption of CRRT in ICU patients and strategic partnerships with global players.

Competitive Landscape

The market is consolidated, with Baxter, Fresenius Medical Care AG & Co. KGaA, and B Braun SE holding substantial shares. Innovations such as B. Braun's acquisition of Intermedt Medizin & Technik GmbH in March 2022 and Baxter's strategic spin-offs demonstrate the focus on expanding CRRT offerings.

Conclusion

The global CRRT market is projected to expand steadily from USD 1.25 billion in 2025 to USD 2.52 billion by 2034, driven by increasing AKI prevalence, rising ICU admissions, technological innovations, and expanding pediatric and home-based CRRT solutions. North America continues to dominate, while Asia Pacific offers the fastest growth. Consumables and CVVHDF modalities lead the market. Strategic product development and adoption of AI-integrated and user-friendly CRRT systems will further enhance patient outcomes and global market expansion.

Segmentation By Product Type

  • Systems
  • Consumables
    • Dialysates
    • Replacement Solutions
    • Filters
    • Catheters
    • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Region

  • North America (By Product Type, By Modality, By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Modality, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Modality, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Modality, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Modality, By Country/Sub-Region)
    • South Africa
    • GCC
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Epidemiology of Acute Kidney Failure by Key Countries, 2025
  • 4.2. Reimbursement Scenario for Key Countries/Regions
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments Mergers, Acquisitions, and Partnerships
  • 4.5. Impact of Covid-19 on the Market

5. Global Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Systems
    • 5.1.2. Consumables
      • 5.1.2.1. Dialysates
      • 5.1.2.2. Replacement Solutions
      • 5.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 5.1.2.4. Catheters
      • 5.1.2.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Systems
    • 6.1.2. Consumables
      • 6.1.2.1. Dialysates
      • 6.1.2.2. Replacement Solutions
      • 6.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 6.1.2.4. Catheters
      • 6.1.2.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Systems
    • 7.1.2. Consumables
      • 7.1.2.1. Dialysates
      • 7.1.2.2. Replacement Solutions
      • 7.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 7.1.2.4. Catheters
      • 7.1.2.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Systems
    • 8.1.2. Consumables
      • 8.1.2.1. Dialysates
      • 8.1.2.2. Replacement Solutions
      • 8.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 8.1.2.4. Catheters
      • 8.1.2.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Systems
    • 9.1.2. Consumables
      • 9.1.2.1. Dialysates
      • 9.1.2.2. Replacement Solutions
      • 9.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 9.1.2.4. Catheters
      • 9.1.2.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Systems
    • 10.1.2. Consumables
      • 10.1.2.1. Dialysates
      • 10.1.2.2. Replacement Solutions
      • 10.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 10.1.2.4. Catheters
      • 10.1.2.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Modality
    • 10.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 10.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 10.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 10.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.3.1. South Africa
    • 10.3.2. GCC
    • 10.3.3. Rest of Middle East Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Baxter
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Fresenius Medical Care AG & Co. KGaA
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. NIPRO Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Toray Medical Co., Ltd (TORAY INDUSTRIES, INC.)
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Nikkiso Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medtronic
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 02: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 03: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 04: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Region, 2021-2034
  • Table 05: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 06: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 07: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 08: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 09: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 10: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables 2021-2034
  • Table 11: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 12: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 14: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 15: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 16: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 18: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 19: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 20: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 22: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 23: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 24: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 02: Global Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 03: Global Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025 & 2034
  • Figure 04: Global Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Region, 2025 & 2034
  • Figure 05: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 06: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product, 2025
  • Figure 07: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 08: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 09: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country, 2025
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 30: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 32: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 33: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Market Share (%), By Company, 2025